Anti-Factor XIIIa antibody [AC-1A1]
| Name | Anti-Factor XIIIa antibody [AC-1A1] |
|---|---|
| Supplier | Abcam |
| Catalog | ab1834 |
| Prices | $392.00 |
| Sizes | 500 µl |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | AC-1A1 |
| Applications | ICC/IF ICC/IF ELISA IHC-P IHC-F WB FC |
| Species Reactivities | Mouse, Human |
| Antigen | BALB/C mice were injected with recombinant human protein corresponding to A-subunit of coagulation Factor XIII |
| Description | Mouse Monoclonal |
| Gene | F13A1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab1834 - immunohistochemistry Formalin fixed paraffin embedded human placenta stained with Factor XIIIa, using ABC and AEC chromogen.
ab1834 staining human placenta by IHC-P.
![Anti-Factor XIIIa antibody [AC-1A1] (ab1834) at 1/250 dilution + Placenta (Human) Tissue Lysate - adult normal tissue (ab29745) at 10 µgSecondaryGoat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/5000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/16555_Factor-XIIIa-Primary-antibodies-ab1834-2.jpg)
Anti-Factor XIIIa antibody [AC-1A1] (ab1834) at 1/250 dilution + Placenta (Human) Tissue Lysate - adult normal tissue (ab29745) at 10 µgSecondaryGoat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/5000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human placenta tissue, staining Factor XIIIa with ab1834.
![Overlay histogram showing A549 cells stained with ab16956 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab16956, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/16557_Factor-XIIIa-Primary-antibodies-ab1834-4.jpg)
Overlay histogram showing A549 cells stained with ab16956 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab16956, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
Product References
Regulation of gene expression by PI3K in mouse growth plate chondrocytes. - Regulation of gene expression by PI3K in mouse growth plate chondrocytes.
Ulici V, James CG, Hoenselaar KD, Beier F. PLoS One. 2010 Jan 25;5(1):e8866.
Association of coagulation factor XIII-A with Golgi proteins within - Association of coagulation factor XIII-A with Golgi proteins within
Cordell PA, Kile BT, Standeven KF, Josefsson EC, Pease RJ, Grant PJ. Blood. 2010 Apr 1;115(13):2674-81.
Fibrofolliculoma/trichodiscoma and fibrous papule (perifollicular - Fibrofolliculoma/trichodiscoma and fibrous papule (perifollicular
Misago N, Kimura T, Narisawa Y. J Cutan Pathol. 2009 Sep;36(9):943-51.
Differential rates of replacement of human dermal dendritic cells and macrophages - Differential rates of replacement of human dermal dendritic cells and macrophages
Haniffa M, Ginhoux F, Wang XN, Bigley V, Abel M, Dimmick I, Bullock S, Grisotto M, Booth T, Taub P, Hilkens C, Merad M, Collin M. J Exp Med. 2009 Feb 16;206(2):371-85.
Immediate mineralocorticoid receptor blockade improves myocardial infarct healing - Immediate mineralocorticoid receptor blockade improves myocardial infarct healing
Fraccarollo D, Galuppo P, Schraut S, Kneitz S, van Rooijen N, Ertl G, Bauersachs J. Hypertension. 2008 Apr;51(4):905-14.